Important Safety Information
Prescribing Information
Medication Guide
Clinical References
References Request
Why Vibativ
Potency
Dual MOA
Dosing
Safety Info
HABP/VABP
Treating HABP/VABP
Subgroups
Lung Penetration
Concurrent Bacteremia
cSSSI
TREATING cSSSI
Subgroups
Tissue Penetration
Concurrent Bacteremia
Real World Results
Outcomes
Setting Of Care
Pathogens
Order of Therapy
Adverse Effects
Access
Order
Storage and Handling
Billing
MIC Test Strips
Patient Identifier
Why Vibativ
Potency
Dual MOA
Dosing
Safety Info
HABP/VABP
Treating HABP/VABP
Subgroups
Lung Penetration
Concurrent Bacteremia
cSSSI
TREATING cSSSI
Subgroups
Tissue Penetration
Concurrent Bacteremia
Real World Results
Outcomes
Setting Of Care
Pathogens
Order of Therapy
Adverse Effects
Access
Order
Storage and Handling
Billing
MIC Test Strips
Patient Identifier
SUBGROUPS
VIBATIV Clinical Cure Rates at the Test-of-Cure for the Most Common Pathogens in cSSSI
1